Title : Quantification of the Contribution of GLP-1 to Mediating Insulinotropic Effects of DPP-4 Inhibition With Vildagliptin in Healthy Subjects and Patients With Type 2 Diabetes Using Exendin [9-39] as a GLP-1 Receptor Antagonist.

Pub. Date : 2016 Aug

PMID : 27207543






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vildagliptin treatment more than doubled responses of intact GLP-1 and glucose-dependent insulinotropic polypeptide and lowered glucose responses without changing AUCISR/AUCglucose in healthy subjects. Vildagliptin gastric inhibitory polypeptide Homo sapiens